HomeLPCN • NASDAQ
add
Lipocine Inc
Previous close
$5.23
Day range
$4.82 - $5.24
Year range
$3.04 - $11.79
Market cap
26.15M USD
Avg Volume
34.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.63M | -32.92% |
Net income | -2.22M | 66.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.62M | 62.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.82M | -16.88% |
Total assets | 20.70M | -16.38% |
Total liabilities | 1.58M | -30.37% |
Total equity | 19.12M | — |
Shares outstanding | 5.35M | — |
Price to book | 1.46 | — |
Return on assets | -30.08% | — |
Return on capital | -32.30% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.22M | 66.64% |
Cash from operations | -2.83M | -8.71% |
Cash from investing | 1.02M | -17.74% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.81M | -92.19% |
Free cash flow | -2.08M | 35.14% |
About
Founded
1997
Headquarters
Website
Employees
17
